A. Balanean

The Use and Knowledge of Validated Geriatric Assessment Instruments Among US Community Oncologists

A. Gajra, B. Feinberg, H. Klepin, 2022, JCO oncology practice.

Clinical Outcomes at 3 and 6 Months of Fedratinib Therapy Following Prior Ruxolitinib Failure: Real-World Assessment of Spleen, Symptoms, and Hematologic Response

C. Harrison, J. Mascarenhas, B. Feinberg, 2021, Blood.

Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review

Abigail Silva, Hunter K. Holt, Abigail H. Goben, 2020, Cancer Causes & Control.

Reducing Avoidable Emergency Visits and Hospitalizations With Patient Risk-Based Prescriptive Analytics: A Quality Improvement Project at an Oncology Care Model Practice

A. Gajra, John W. Showalter, R. Page, 2023, JCO oncology practice.

Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer

A. Gajra, J. Kish, J. Ivanova, 2023, The oncologist.

Oncologist Perceptions of Racial Disparity, Racial Anxiety, and Unconscious Bias in Clinical Interactions, Treatment, and Outcomes.

A. Gajra, Y. Jeune-Smith, A. Balanean, 2024, Journal of the National Comprehensive Cancer Network : JNCCN.

Real-world clinical outcomes and rationale for initiating abatacept as a first-line biologic for patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis

C. Brown-Bickerstaff, A. Balanean, Vadim Khaychuk, 2024, Journal of comparative effectiveness research.